These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12603221)

  • 1. Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation.
    Troppmann C; Rossaro L; Perez RV; McVicar JP
    Am J Transplant; 2003 Feb; 3(2):239-40. PubMed ID: 12603221
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection.
    Nuovo GJ; Holly A; Wakely P; Frankel W
    Hum Pathol; 2002 Mar; 33(3):277-84. PubMed ID: 11979367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
    Kwo PY; Saxena R; Cummings OW; Tector AJ
    Liver Transpl; 2007 Dec; 13(12):1710-3. PubMed ID: 18044743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation.
    Pessoa MG; Bzowej N; Berenguer M; Phung Y; Kim M; Ferrell L; Hassoba H; Wright TL
    Hepatology; 1999 Dec; 30(6):1513-20. PubMed ID: 10573532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.
    Fukuhara T; Morita K; Takeishi K; Toshima T; Umeda K; Nagata S; Sugimachi K; Ikegami T; Gion T; Soejima Y; Taketomi A; Maehara Y
    Surg Today; 2010 Oct; 40(10):982-5. PubMed ID: 20872205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestatic hepatitis C in liver allografts.
    Taga SA; Washington MK; Terrault N; Wright TL; Somberg KA; Ferrell LD
    Liver Transpl Surg; 1998 Jul; 4(4):304-10. PubMed ID: 9649645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.
    Fenwick F; Bassendine MF; Agarwal K; Bevitt D; Pumeechockchai W; Burt AD; Toms GL
    J Clin Pathol; 2006 Feb; 59(2):174-8. PubMed ID: 16443734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV: alive and kicking in living donor liver grafts?
    Forns X
    Hepatology; 2005 Dec; 42(6):1258-60. PubMed ID: 16317701
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrahepatic cholestasis following liver transplantation.
    Te HS; Baker AL
    Clin Liver Dis; 1999 Aug; 3(3):633-49, x. PubMed ID: 11291242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hepatitis Aggressiveness Score (HAS): a novel classification system for post-liver transplantation recurrent hepatitis C.
    Moreira RK; Salomao M; Verna EC; Brown RS; Lefkowitch JH
    Am J Surg Pathol; 2013 Jan; 37(1):104-13. PubMed ID: 23060356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels.
    Doughty AL; Spencer JD; Cossart YE; McCaughan GW
    Liver Transpl Surg; 1998 Jan; 4(1):15-21. PubMed ID: 9457962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.
    Goldaracena N; Barbas AS; Galante A; Sapisochin G; Al-Adra D; Selzner N; Galvin Z; Cattral MS; Greig PD; Lilly L; Bhat M; McGilvray ID; Ghanekar A; Levy G; Grant DR; Selzner M
    Clin Transplant; 2018 Aug; 32(8):e13304. PubMed ID: 29947154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-28B polymorphisms are associated with fibrosing cholestatic hepatitis in recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Zein NN; Askar M; Lopez R; John B
    Clin Transplant; 2012; 26(4):E335-6. PubMed ID: 22762459
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation.
    Horster S; Bäuerlein FJ; Mandel P; Raziorrouh B; Hopf C; Stemmler HJ; Guba M; Angele M; Stangl M; Rentsch M; Frey L; Kaspar M; Kaczmarek I; Eberle J; Nickel T; Gruener N; Zachoval R; Diepolder H
    Transpl Infect Dis; 2013 Jun; 15(3):306-13. PubMed ID: 23489913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.
    Song AT; Mello ES; Alves VA; Cavalheiro Nde P; Melo CE; Bonazzi PR; Tengan FM; Freire MP; Barone AA; D'Albuquerque LA; Abdala E
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):56-64. PubMed ID: 25742264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.